Esperion Therapeutics Inc (NASDAQ: ESPR) is 8.70% higher on its value in year-to-date trading and has touched a low of $1.35 and a high of $3.44 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ESPR stock was last observed hovering at around $3.10 in the last trading session, with the day’s gains setting it 0.15%.
Currently trading at $3.25, the stock is 32.90% and 50.62% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.47 million and changing 4.84% at the moment leaves the stock 46.28% off its SMA200. ESPR registered 125.69% gain for a year compared to 6-month loss of 44.44%. The firm has a 50-day simple moving average (SMA 50) of $2.1254 and a 200-day simple moving average (SMA200) of $2.21905.
The stock witnessed a 60.10% gain in the last 1 month and extending the period to 3 months gives it a 78.57%, and is 26.46% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.97% over the week and 8.93% over the month.
Esperion Therapeutics Inc (ESPR) has around 240 employees, a market worth around $640.37M and $295.45M in sales. Fwd P/E is 9.47. Profit margin for the company is -29.37%. Distance from 52-week low is 141.64% and -5.52% from its 52-week high. The company has generated returns on investments over the last 12 months (-58.53%).
with sales reaching $61.56M over the same period.The EPS is expected to grow by 84.69% this year, but quarterly earnings will post 178.29% year-over-year. Quarterly sales are estimated to grow 90.87% in year-over-year returns.
Esperion Therapeutics Inc (ESPR) Top Institutional Holders
223.0 institutions hold shares in Esperion Therapeutics Inc (ESPR), with institutional investors hold 66.66% of the company’s shares. The shares outstanding are 195.44M, and float is at 195.06M with Short Float at 16.02%. Institutions hold 66.33% of the Float.
The top institutional shareholder in the company is WASATCH ADVISORS LP with over 16.86 million shares valued at $37.44 million. The investor’s holdings represent 9.9628% of the ESPR Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 13.98 million shares valued at $31.04 million to account for 8.2617 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 10.82 million shares representing 6.3907% and valued at over $24.01 million, while BELLEVUE GROUP AG holds 5.8751 of the shares totaling 9.94 million with a market value of $22.08 million.
Esperion Therapeutics Inc (ESPR) Insider Activity
The most recent transaction is an insider sale by Warren Eric, the company’s Chief Commercial Officer. SEC filings show that Warren Eric sold 197 shares of the company’s common stock on Nov 19 ’24 at a price of $2.17 per share for a total of $427.0. Following the sale, the insider now owns 0.16 million shares.
Still, SEC filings show that on Oct 17 ’24, Warren Eric (Chief Commercial Officer) disposed off 107 shares at an average price of $2.12 for $227.0. The insider now directly holds 162,552 shares of Esperion Therapeutics Inc (ESPR).
